Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study

被引:0
|
作者
Lorenzo Iughetti
Gianluca Tornese
Maria Elisabeth Street
Flavia Napoli
Claudia Giavoli
Franco Antoniazzi
Stefano Stagi
Caterina Luongo
Sara Azzolini
Letizia Ragusa
Gianni Bona
Clara Zecchino
Tommaso Aversa
Luca Persani
Laura Guazzarotti
Emiliano Zecchi
Alberto Pietropoli
Stefano Zucchini
机构
[1] University of Modena and Reggio Emilia,Pediatric Unit, Department of Medical and Surgical Sciences for Mother, Children and Adults
[2] Institute for Maternal and Child Health IRCCS Burlo Garofolo,Pediatric Unit
[3] Department of Paediatrics- Arcispedale S. Maria Nuova-IRCCS,Endocrinology and Metabolic Diseases Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
[4] Istituto Giannina Gaslini,Pediatric Unit, Policlinico Giambattista Rossi
[5] Università degli Studi di Milano,Health Science Department, Anna Meyer Children’s University Hospital
[6] University of Verona,Department of Woman, Child and General and Specialized Surgery
[7] University of Florence,Pediatric Endocrinology Unit, Department of Woman’s and Child’s Health
[8] Seconda Università degli Studi di Napoli,Division of Paediatrics
[9] University Hospital of Padua,Department of Sciences and Pediatric Surgery
[10] UOC Pediatria,Department of Human Pathology of Adulthood and Childhood
[11] I.R.C.S.S. Oasi Maria SS,Department of Clinical Sciences and Community Health
[12] Azienda Ospedaliero-Universitaria Maggiore della Carità,Department of Paediatrics, Paediatric Endocrinology Unit
[13] University of Bari “A. Moro”,Unit of Pediatric Endocrinology
[14] University of Messina,undefined
[15] University of Milan,undefined
[16] Division of Endocrine and Metabolic Diseases,undefined
[17] IRCCS Istituto Auxologico Italiano,undefined
[18] University of Milan,undefined
[19] Sandoz S.p.A,undefined
[20] Hexal AG,undefined
[21] S.Orsola-Malpighi Hospital,undefined
关键词
Adolescents; Children; Infants; Omnitrope®; Paediatric; Recombinant human growth hormone;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study
    Iughetti, Lorenzo
    Tornese, Gianluca
    Street, Maria Elisabeth
    Napoli, Flavia
    Giavoli, Claudia
    Antoniazzi, Franco
    Stagi, Stefano
    Luongo, Caterina
    Azzolini, Sara
    Ragusa, Letizia
    Bona, Gianni
    Zecchino, Clara
    Aversa, Tommaso
    Persani, Luca
    Guazzarotti, Laura
    Zecchi, Emiliano
    Pietropoli, Alberto
    Zucchini, Stefano
    ITALIAN JOURNAL OF PEDIATRICS, 2016, 42
  • [2] Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope®) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study
    Iughetti, Lorenzo
    Antoniazzi, Franco
    Giavoli, Claudia
    Bellone, Simonetta
    Aversa, Tommaso
    Guazzarotti, Laura
    Street, Maria Elisabeth
    del Giudice, Emanuele Miraglia
    Persani, Luca
    Pozzobon, Gabriella
    Ragusa, Letizia
    Stagi, Stefano
    Tornese, Gianluca
    Zecchino, Clara
    Mameli, Chiara
    Zecchi, Emiliano
    Fedeli, Paolo
    Zabransky, Markus
    Lucaccioni, Laura
    Zucchini, Stefano
    ENDOCRINE, 2025, 87 (03) : 933 - 942
  • [3] Safety and effectiveness of a somatropin biosimilar in children requiring growth hormone treatment: second analysis of the PATRO Children study Italian cohort
    Iughetti, L.
    Antoniazzi, F.
    Giavoli, C.
    Bona, G.
    Aversa, T.
    Greggio, N. A.
    Guazzarotti, L.
    Minelli, R.
    Perrone, L.
    Persani, L.
    Pozzobon, G.
    Ragusa, L.
    Stagi, S.
    Tornese, G.
    Zecchino, C.
    Gallinari, P.
    Zouater, H.
    Fedeli, P.
    Zucchini, S.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (03) : 493 - 503
  • [4] Safety and effectiveness of a somatropin biosimilar in children requiring growth hormone treatment: second analysis of the PATRO Children study Italian cohort
    L. Iughetti
    F. Antoniazzi
    C. Giavoli
    G. Bona
    T. Aversa
    N. A. Greggio
    L. Guazzarotti
    R. Minelli
    L. Perrone
    L. Persani
    G. Pozzobon
    L. Ragusa
    S. Stagi
    G. Tornese
    C. Zecchino
    P. Gallinari
    H. Zouater
    P. Fedeli
    S. Zucchini
    Journal of Endocrinological Investigation, 2021, 44 : 493 - 503
  • [5] Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study
    D. Ferone
    E. Profka
    V. Gasco
    M. R. Ambrosio
    A. Colao
    C. Di Somma
    E. Puxeddu
    G. Arnaldi
    C. Pagano
    E. Zecchi
    A. Pietropoli
    P. Beck-Peccoz
    Journal of Endocrinological Investigation, 2017, 40 : 669 - 678
  • [6] Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope((R)) in children requiring growth hormone treatment
    Pfaeffle, Roland
    Schwab, Karl Otfried
    Marginean, Otilia
    Walczak, Mieczyslaw
    Szalecki, Mieczyslaw
    Schuck, Ellen
    Zabransky, Markus
    Zucchini, Stefano
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2013, 4 (01) : 3 - 11
  • [7] Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope®) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study (Nov, 10.1007/s12020-024-04090-x, 2024)
    Iughetti, Lorenzo
    Antoniazzi, Franco
    Giavoli, Claudia
    Bellone, Simonetta
    Aversa, Tommaso
    Guazzarotti, Laura
    Street, Maria Elisabeth
    Miraglia del Giudice, Emanuele
    Persani, Luca
    Pozzobon, Gabriella
    Ragusa, Letizia
    Stagi, Stefano
    Tornese, Gianluca
    Zecchino, Clara
    Mameli, Chiara
    Zecchi, Emiliano
    Fedeli, Paolo
    Zabransky, Markus
    Lucaccioni, Laura
    Zucchini, Stefano
    ENDOCRINE, 2025,
  • [8] Latest Results from PATRO Children, A Multi-Centre, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment
    Kanumakala, Shankar
    Pfaffle, Roland
    Hoybye, Charlotte
    Kristrom, Berit
    Battelino, Tadej
    Zabransky, Markus
    Zouater, Hichem
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 124 - 124
  • [9] LATEST RESULTS FROM PATRO CHILDREN, A MULTI-CENTRE, NON-INTERVENTIONAL STUDY OF THE LONG-TERM SAFETY AND EFFICACY OF OMNITROPE® IN CHILDREN REQUIRING GROWTH HORMONE TREATMENT
    Pfaeffle, Roland W.
    Kanumakala, Shankar
    Hoybye, Charlotte
    Kristrom, Berit
    Battelino, Tadej
    Colle, Michel
    Zabransky, Markus
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 485 - 486
  • [10] Latest results from PATRO Children, a multi-centre, observational study of the long-term safety and effectiveness of Omnitrope® in children requiring growth hormone treatment
    Kanumakala, Shankar
    Pfaeffle, Roland
    Hoybye, Charlotte
    Kristrom, Berit
    Battelino, Tadej
    Zabransky, Markus
    Zouater, Hichem
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 239 - 240